|
(MoneyNewsWire.Net, March 07, 2018 ) The global cellular health screening market is expected to reach USD 3.42 Billion by 2022 from USD 2.12 Billion in 2017, at a CAGR of 10.0% during the forecast period. A number of factors such as increasing adoption of telomere performance programs for leading a healthy life; growing importance of healthy life expectancy (HALE); rising government focus towards preventive healthcare; rising geriatric population and resultant growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach; and the increasing burden of chronic diseases are driving the demand for global cellular health screening. On the other hand, problems associated with the transport of samples and differences in the cost of test kits offered by different companies are some of the factors that may hinder the overall growth of this market.
Browse Market Data Tables and In-Depth TOC of the Cellular Health Screening/Health Testing Market to 2022 @ https://www.researchcosmos.com/reports/global-cellular-health-screening-health-testing-market-analysis-and-forecast-to-2022-gro/2270490
This report segments the global cellular health screening market into type, sample type, sample collection site, and region. On the basis of type, the global cellular health screening market is segmented single test panels and multi-test panels. The multi-test panels segment is expected to grow at the highest CAGR during the forecast period. The preference for multi-test panels is increasing in the market as they provide results for multiple biomarkers in a single exam.
The global cellular health screening market, by sample type is segmented into blood samples and other samples. In 2017, the blood samples segment is expected to account for the largest share of the market. The large share and high growth of this segment can primarily be attributed to the advantages associated with the use of blood samples, such as the accuracy and reliability of test results.
Request Free Sample @ https://www.researchcosmos.com/request/2270490
By sample collection site, the global cellular health screening market is segmented into at-home, in-office, and other sample collection sites. In 2017, the at-home segment is expected to account for the largest share of the market. The large share of this segment can be attributed to the availability of diagnostic and therapeutic products that can be used by patients at home without assistance from healthcare professionals.
In 2017, North America is expected to dominate the global cellular health screening market. Factors such as growing government focus towards preventive healthcare, increasing burden of chronic diseases, increasing research activities, rising geriatric population, and growing number of local players operating in the region are expected to drive the growth of this regional segment.
Inquire before buying @ https://www.researchcosmos.com/inquire/2270490
The global cellular health screening market is highly competitive with the presence of several small and big players. Prominent players in the cellular heath screening market include Genova Diagnostics (U.S.), Telomere Diagnostics (U.S.), Life Length (Spain), Quest Diagnostics (U.S.), Repeat Diagnostics (Canada), SpectraCell Laboratories (U.S.), Zimetry LLC (U.S.), Cell Science Systems (U.S.), Titanovo, Inc. (U.S.), Segterra, Inc. (U.S.), LabCorp Holdings (U.S.), BioReference Laboratories (U.S.), Immundiagnostik AG (Germany), DNA Labs (India), and Cleveland HeartLab, Inc. (U.S.).
About Us:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Contact Us:
Dani Rodriguez
Research Cosmos
+1 888 709 8757
dani@researchcosmos.com <||>rnhttps://www.researchcosmos.com
Research Cosmos
Dani Rodriguez
+1 888 709 8757
dani@researchcosmos.com
Source: EmailWire.Com 
|
